During the pandemic, Zoom grew exponentially. With the quarantine and confinement, it was an indispensable tool for scheduling work, study and even family meetings. However, the twilight of the pandemic is going down quite badly for him.
As recently reported, the company is in share terms 90% below its maximum reached during October 2020, at the height of the pandemic. Two things happened at the same time: annual sales fell and, at the same time, quarterly growth was slower than expected.
Specifically, the Actions they fell 4.73% and its current price is $76.46. In addition, its competitors such as Teams, from Microsoft, Webex, from Cisco and Slack, from Salesforce, have grown intensely.
“Zoom it has a fundamental flaw: it has needed to spend a lot to maintain its market share. Spending to hold on to market share, rather than grow it, is never good and is a sign of trouble ahead,” said Sophie Lund-Yates, equity analyst at Hargreaves Lansdown.
And you, do you use Zoom?
